Effects of therapy with angiotensin-converting enzyme inhibitor in elderly patients with cardiovascular disease

被引：0
|
作者：
Kolasinska-Malkowska, Katarzyna [1 ]
Cwynar, Marcin [2 ]
机构：
[1] Uniwersytet Med Karola Marcinkowskiego, Katedra & Klin Hipertensjol Angiol & Chorob Wewne, Ul Dluga 1-2, PL-61848 Poznan, Poland
[2] Uniwersytetu Jagiellonskiego Krakowie, Collegium Medicum, Katedra Chorob Wewnetrznych & Gerontol, Krakow, Poland
来源：
ARTERIAL HYPERTENSION | 2008年 / 12卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：67 / 71
页数：5
相关论文
共 50 条
  • [1] Should an angiotensin-converting enzyme inhibitor be standard therapy for patients with atherosclerotic disease?
    O'Keefe, JH
    Wetzel, M
    Moe, RR
    Brosnahan, K
    Lavie, CJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (01) : 1 - 8
  • [2] ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR THERAPY
    OPIE, LH
    PRZYBOJEWSKI, JZ
    SOUTH AFRICAN MEDICAL JOURNAL, 1992, 81 (04): : 183 - 185
  • [3] Angiotensin-converting enzyme inhibitor dosages in elderly patients with heart failure
    Chen, YT
    Wang, Y
    Radford, MJ
    Krumholz, HM
    AMERICAN HEART JOURNAL, 2001, 141 (03) : 410 - 417
  • [4] Angiotensin-converting enzyme and cardiovascular disease risk
    O'Malley, JP
    Maslen, CL
    Illingworth, DR
    CURRENT OPINION IN LIPIDOLOGY, 1999, 10 (05) : 407 - 415
  • [5] Effects of combination therapy of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker
    Idrizi, A
    Gjata, M
    Barbullushi, M
    Koroshi, A
    Tase, M
    Sadiku, E
    Hoti, K
    JOURNAL OF HYPERTENSION, 2005, 23 : S398 - S398
  • [6] Serial investigation of Angiotensin-Converting Enzyme in sarcoidosis patients treated with Angiotensin-Converting Enzyme Inhibitor
    d'Alessandro, Miriana
    Bergantini, Laura
    Perrone, Anna
    Cameli, Paolo
    Cameli, Matteo
    Prasse, Antje
    Plataroti, Dario
    Sestini, Piersante
    Bargagli, Elena
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2020, 78 : 58 - 62
  • [7] Angiotensin-converting enzyme inhibitor therapy in nonobstructive coronary artery disease
    Manfrini, O.
    Morrell, C.
    Das, R.
    Barth, J. H.
    Bugiardini, R.
    Hall, A. S.
    EUROPEAN HEART JOURNAL, 2011, 32 : 485 - 485
  • [8] Ordering of the Serum Angiotensin-Converting Enzyme Test in Patients Receiving Angiotensin-Converting Enzyme Inhibitor Therapy An Avoidable but Common Error
    Krasowski, Matthew D.
    Savage, Johanna
    Ehlers, Alexandra
    Maakestad, Jon
    Schmidt, Gregory A.
    La'ulu, Sonia L.
    Rasmussen, Natalie N.
    Strathmann, Frederick G.
    Genzen, Jonathan R.
    CHEST, 2015, 148 (06) : 1447 - 1453
  • [9] Angiotensin-converting enzyme inhibitor/angiotensinIIreceptor blocker treatment and haemodynamic factors are associated with increased cardiacmRNAexpression of angiotensin-converting enzyme2in patients with cardiovascular disease
    Lebek, Simon
    Tafelmeier, Maria
    Messmann, Rebecca
    Provaznik, Zdenek
    Schmid, Christof
    Maier, Lars S.
    Birner, Christoph
    Arzt, Michael
    Wagner, Stefan
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (12) : 2248 - 2257
  • [10] Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure
    McNamara, DM
    Holubkov, R
    Postava, L
    Janosko, K
    MacGowan, GA
    Mathier, M
    Murali, S
    Feldman, AM
    London, B
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (10) : 2019 - 2026
12345